Grant Awards in April 2004
Preface >>
Facts and Figures >>
| Principal Investigator | Project Title/Link |
|
Dr. José Cohen Hôpital de la Pitié-Salpêtrière-Cervi, Paris, France |
Generation of Foxp3-Transduced CD4+ Suppressive T Cells for Induction of Tolerance in Transplantation |
|
Prof. Jay A. Fishman Massachusetts General Hospital, Boston, USA |
The Role of Viral Infection in the Development of Post-Transplant Cancers |
|
Prof. Andrew George Imperial College London, Hammersmith Campus, London, UK |
Modification of Dendritic Cells and DNA Vaccination for the Induction of Tolerance |
|
Dr. Holger Hackstein Justus Liebig University Giessen, Giessen, Germany |
Sanglifehrin A, a Novel Immunophilin-Binding Agent with Unique Activity against Dendritic Cells |
|
Prof. Robert Lechler King's College London, Guy's Campus, London, UK |
Promoting Transplantation Tolerance: Adoptive T Cell Therapy Using Customised Regulatory Cells |
|
Dr. Olivia Martinez Stanford University School of Medicine, Stanford, USA |
B Cell Lymphomas in Transplantation |
|
Dr. Volker Nickeleit The University of North Carolina, Chapel Hill, USA |
BK-Virus Load Measurements in Kidneys: New Strategies for Assessing the Risk of BK-Virus Nephropathy |
|
Prof. Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research, Bergamo, Italy |
Donor Engineered Dendritic Cells to Generate Tolerogenic Regulatory T Cells for Renal Transplantation |
|
Prof. Ann M. Simpson University of Technology Sydney, St. Leonards, Australia |
Correction of Diabetes Using Primary Liver Cells |
|
Prof. Angus W. Thomson University of Pittsburgh, Pittsburgh, USA |
Plasmacytoid Dendritic Cells and Liver Transplant Tolerance |
|
Dr. Cees van Kooten Leiden University Medical Center, Leiden, The Netherlands |
Survival Mechanisms of Human Dendritic Cells as a Tool to Direct Immune Response |
|
Dr. Barbara A. Wasowska Johns Hopkins University SOM, Baltimore, USA |
The Role of Antibodies in Allograft Rejection |
